Enclosed

Date: August 14, 2026 Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 524790 Dear Sir/Madam, Sub: Outcome of the Board Meeting held on Friday, August 14, 2026 – Un-audited Standalone Financial Results for the Quarter ended June 30, 2026 Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that the Meeting of the Board of Directors of the Company was held today, Friday, August 14, 2026. The meeting commenced at 11:30 a.m. (IST) and, after considering the appointment of Directors and the re- constitution of Committees, was adjourned at 12:00 Noon (IST) to enable a meeting of the re-constituted Audit Committee. The Board Meeting was thereafter reconvened at 01:30 p.m. (IST) and concluded at 4:10 p.m. (IST). The Board, inter-alia, discussed and approved the following items of business: 1. Approved the Un-audited Standalone Financial Results of the Company for the quarter ended June 30, 2026. 2. Noted the Limited Review Report issued by the Statutory Auditors, Mr. Yadavilli Sai Karunakar (M.No. 207033), Partner, P.S.N. Ravishanker & Associates, FRN-003228S, on the aforementioned Un-audited Financial Results for the quarter ended June 30, 2026. Enclosed herewith are the Un-audited Standalone Financial Results of the Company for the quarter ended June 30, 2026, along with the Notes thereto and the Limited Review Report issued by the Statutory Auditors on the aforementioned results. We request you to kindly take the above information on record. Yours faithfully, For Everest Organics Limited Sirisha Srikakarlapudi Managing Director & CEO DIN: 06921012 Encl: A/a. EVE ED (ClN : L24230TG1 STATEMENT OF UNAUDITEO FTNANCIAL RESULTS FOR THE OUARIER ENDED 3oth JIJNE, 2026 Ouarter Ended S,NO 30th Jun 2026 31st Mar 2026 30th Jun 2025 31sl Mar.2026 1 132 19 615 77 41 89 15 95 54 96 1 884.95 4 490 77 .24 197 Cost 2800 22 3.304 44 51 12 .07 43219 4'l 165 56 1 Ern 366.86 160 395.99 1 548 43 162.89 27574 6 652 7A 158.8 193 01 15152 64n 29 F=Other 811.07 1 oaa 24 836.60 3750 46 732.1'l 673 9.85 i8 152.44 2'17.15 2 6.43 404 63 5 152.84 2'17.15 216.43 804.68 TB7 15?.44 217.15 216.43 8 1 Currcnt 73.00 51.11 226.O4 2 31.50 968 39.79 24 02 9 111.31 262 140.52 554.65 13 11'1.34 262.93 140.52 554_65 111.34 262.93 110.52 554 55 15 Other C llems that will nol be reclassined lo 1 1 noi be reclassined lo Profii or Loss 0.63 0.63 a llems thalwiLl be reclassiiied lo lo items lhatwillbe redassified lo Profil or Loss olalOlherCom 16 13+15 11'l _34 261.41 140.52 553.13 Tolal Comp.ehensive lncome tor lhe pedod altibutable lo prising Proril (ross) and olher 1 18 9 Revaluation ReserS veh sares ol Rs. 101 each 971 0 tl5 971.0 75 6.9 17 61 10 55 971 0 20 Eam tNot Annuarsd I 115 2.71 145 l Diuted 1.15 2-t1 145 5.71 Share ror Discontinued O Baslc T Diuled 20(iiD Earn Share for Disconlinued And Conlin EasLc 1 15 271 1 71 Diluled 1.15 2.71 45 571 me above unaldited financial results ol Everest Limited {"the Company") have b€en prepared in accordance wilh lhe lnd AS prescribed under Seclion 133 of lhs companies Act,2013 ("the Acr), read wiin tho releva.r rures issued Ihereuoder and other accounlang PdnciPles gercrally accepted in lndia in Iems of Regllalion 33 olthe Securiies and Exchange Board ot lndia (Lasling Obrigalons and Dlsclosure Requiremenls) Regulalions,2015, as amended. Th€ above umudited liaancial results for Ue quarter ended 3oth June.2026 w€re reviewed and recommended by lhe Audit commitlee in als moeting held on 14-0&2026 and thereaner approved aId taken on record by lhe Boad oI Directo.s in its meeting held on lhe same d.v. 3 O!n.g lhe 1sr quarter ended as on 3olh Jun,2026, rhe comparry made sales iumover of Rs.4843.00 kkns which @mpnses ol Domeslic Tumover of Rs.3764.83 Lakhs and Expon Tumover of Rs.1078.23 Lakhs. 4 The CompanyOpemles in only one reportabte business segment, that is Active Pharmaceuti@l lngredientr (APl) and their lntemediates 5 Ihere we;2,63,15? Equiry Siare Wa.ranrs oursranding on 30.06.2026, issued eatiier @ Rs.152 each p€r Wanani, ot which 25% ol lhe sLrbscn on moneywas received by lhe Company which were not conside.ed tor the puQose of EPS calculalion in accordan@ wilh lnd AS 33 6 1,80,686equiry sharcs ot Evercst organics Lld are stirr rying under'Eve.esl organics Limited unclaimed suspense Accounl'as on 30.06 2026 Figlres ror lhe quarler ended 31.03.2026 and conesponding qlane. e.ded 31.03.2025 are lhe balancing Igures belw€en audited tigures in.especl of the full o T u;ldited publsn€d year to-dat€ ngures uplo lhe Ihird qlarier of the respecllve nnanoal vearc' 8 Figlres for the Previous Periods have been regrcuped/reanangedrecast wherever considered necessary ttFc"+-r Pr"1r8. Dr.S.K.SlRlS 4!l ,l KERc Managing I DLN:06921012 Daie: oa-2a26 cco Yerfri/lLLl KfA - ,llo.2j7o 33 P'*vD rn CK P.S.N. RAVISHANKER & ASSOCIATES Flat No.205,2nd Floor, B-Block, Kushal Towers, D.No.6-2.975, Khairatabad, Chartered Accountants Hyderabad - 500004, Telangana. N D A Phone; 040 - 23320558 / 23393381 E.mail: psnra@yahoo.com INOEPENDENT AUOITORS' LIMITED REVIEW REP RT ON THE QUARTERLY UNAUDITED FINANCIAL RESULTS OF THE COMPANY PURSUANT TO REGULATION 33 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS REGULATIONS. 2015 AS AMENDED The Board of Directors, Everest Organics Limited. 1. We have reviewed the accompanying stalement of unaudited financial r€sults of Everest Organics Limited (The "Company") for the Quarter ended.30th June 2026, (the "Statement") results for the period from 'l "t Aprll, 2026 lo 30in June, 2026 attached herewith, being submitted by the company pursuant to the requiremenls of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. The Statement which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in lndian Accounting Standard 34 (lnd AS 34) "lnterim Financial Repoftingl' prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in lndia and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to issue a report on the statement based on our review 3. We conducted our review of the statement in accordance with the Standard on Review Engagements (SRE) Z41O,"Review of lnterim Financial lnformation peiormed by the lndependent Auditor of the Entity'' issred by the Institute of Chartered Accountants of lndia. This Standard requires thal we plan and perform the review to obtain moderate assurance as to whether the Stdtement is free of material mis-statement. A Review of interim financial information is limited and consists of making inquiries, primarily of personnel responsible for financial and accounting matters, and applying ?nalytical and other review procedures. A Limited Review is substantially less in scope than an audit cohducted in accordance with Standards on Auditing specifled under Section 143(10) of the Companies Act, 2013, thus provides less assurance than an audit. We have not performed an audit and accordingly we do not express an audit opinion. 4 Based on our review conducted as above, subject to the qualification paragraph hereinafter, nothing has c.me to our attention that causes us to believe that the accompanying statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid lndian Accounting Standards specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in lndia, has not disclosed the information required to be disclosed in terms [Showing first 8,000 characters — download PDF for full document]